QS Investors’s Teladoc Health TDOC Stock Holding History

QS Investors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$428K	Hold	2,569	–	–	0.01%	800
2021 Q1	$467K	Buy	2,569 +800	+45%	+$186K	0.01%	830
2020 Q4	$354K	Buy	+1,769	New	+$360K	﹤0.01%	926
2020 Q3	–	Sell	-5,400	Closed	-$1.03M	–	1514
2020 Q2	$1.03M	Buy	5,400 +100	+2%	+$17.5K	0.01%	714
2020 Q1	$822K	Buy	5,300 +3,200	+152%	+$372K	0.01%	719
2019 Q4	$175K	Sell	2,100 -700	-25%	-$53.3K	﹤0.01%	1211
2019 Q3	$190K	Sell	2,800 -24,200	-90%	-$1.59M	﹤0.01%	1216
2019 Q2	$1.79M	Sell	27,000 -669	-2%	-$39K	0.02%	620
2019 Q1	$1.54M	Sell	27,669 -6,473	-19%	-$395K	0.02%	701
2018 Q4	$1.69M	Buy	34,142 +31,975	+1,476%	+$1.96M	0.02%	610
2018 Q3	$187K	Sell	2,167 -1,709	-44%	-$122K	﹤0.01%	1231
2018 Q2	$225K	Buy	3,876 +3,818	+6,583%	+$186K	﹤0.01%	1173
2018 Q1	$2K	Buy	+58	New	+$2.19K	﹤0.01%	1692

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QS Investors's TDOC Position: Q2 2021 in Review

QS Investors held its Teladoc Health (TDOC) position steady in Q2 2021 at 2,569 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #800.

QS Investors first reported a position in TDOC in Q1 2018 and has held it in 13 quarters since. The position peaked at $1.79M in Q2 2019. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

QS Investors held 2,569 shares of Teladoc Health worth $428K as of Q2 2021.
QS Investors left its Teladoc Health share count unchanged in Q2 2021.
Teladoc Health made up 0.01% of QS Investors's portfolio in Q2 2021, its #800 holding.
QS Investors first reported a position in Teladoc Health in Q1 2018 and has held it in 13 quarters since.
QS Investors's Teladoc Health position peaked at $1.79M in Q2 2019.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.